• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • SK's Skyzoster grabs Korean market share from Merck's Zostavax fiercepharma
    March 15, 2018
    As Merck’s shingles shot Zostavax is challenged by GlaxoSmithKline’s Shingrix in the U.S., it's also quickly yielding market share in South Korea to SK Chemicals’ Skyzoster—and Merck is blaming that on SK’s pricing and marketing tactics.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service